Navigation Links
SuperNova Diagnostics® to Present at Biotech Showcase™ 2011 During J.P. Morgan Healthcare Conference January 10-13
Date:1/5/2011

WASHINGTON, LONDON and HONG KONG, Jan. 5, 2011 /PRNewswire/ -- SuperNova Diagnostics®, Inc., a privately-held global diagnostics company for human and non-human health applications, announced today that Neil J. Campbell, president and CEO, will present at Biotech Showcase 2011 in conjunction with the J.P. Morgan Healthcare Conference in San Francisco, CA.  

Mr. Campbell's presentation will be given at the Parc 55 Wyndham Hotel on Wednesday, January 12, 2011 at 3:30 p.m. PST.  "We are delighted to be presenting at a renowned conference such as Biotech Showcase," said Mr. Campbell.  "Biotech Showcase and the J.P. Morgan Healthcare Conference provide a unique opportunity to present to a diverse group of first-class investors and executives interested in medical and industrial diagnostics."

AmpCrystal®, SuperNova Diagnostics' lead technology and its multiple product formats, allows for minimally trained individuals (advanced CLIA-waived) to test for a wide range of protein analytes and can detect directly un-amplified DNA in humans, animals or environmental samples.  

Time-to-result has been shown in prototypes to be reduced to minutes on the spot versus the hours or days required when sending samples to a central laboratory or processing in regional satellite laboratories.  With three integrated capabilities (sample collector/processor, analytical disposable, and the readout device), the technology is simpler, more robust, faster and significantly less expensive than existing POC systems.

Significant advantages of AmpCrystals are direct detection of samples, simplification of product designs, ability to lower costs of delivery and broaden range of assay formats from the central laboratory.

About SuperNova Diagnostics®, Inc.SuperNova® is a development-stage diagnostics company with a proprietary platform for conducting diagnostics at the site of interest with point-of-care in human health and point-of-use for non-human health applications.  A powerful proprietary nanochemistry, AmpCrystal®, can delivery novel, next generation performance for pathogens, proteins, and directly measure DNA without PCR with ultra-low sensitivity and specificity while not sacrificing a dynamic range of measurements.  SuperNova can be utilized in a wide range of diagnostic formats (lateral flow, self-contained cartridges, microtitre, microarrays, closed systems, research products and OEM). SuperNova® - Putting the Laboratory in the Palm of Your Hand®.

For additional information, please visit www.supernovadiagnostics.com.Media Contacts:Tiberend Strategic Advisors, Inc.(212) 827-0020Tamara Bright, tbright@tiberend.comorFarrell Denby, fdenby@tiberend.com
'/>"/>

SOURCE SuperNova Diagnostics, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Nektar Therapeutics President and CEO, Howard W. Robin, to Present at the 29th Annual J.P. Morgan Healthcare Conference in San Francisco, CA
2. InterMune to Present at J.P. Morgan Healthcare Conference
3. Amicus Therapeutics to Present at the 29th Annual J.P. Morgan Healthcare Conference on Tuesday, January 11, 2011
4. Dendreon Announces Webcast Presentation at J.P. Morgan Healthcare Conference
5. Halozyme Therapeutics to Present at J.P. Morgan Healthcare Conference on January 12
6. PDL BioPharma to Present at the 29th Annual JP Morgan Healthcare Conference
7. VIVUS to Present at the 2011 JP Morgan Healthcare Conference
8. Jazz Pharmaceuticals to Present at the J.P. Morgan Healthcare Conference in San Francisco on January 12
9. HeartWare to Present at the 29th Annual J.P. Morgan Healthcare Conference
10. Pharmasset to Present at the 29th Annual J.P. Morgan Healthcare Conference
11. MAP Pharmaceuticals to Present at the 29th Annual J.P. Morgan Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/11/2016)... 11, 2016 Stem cells are primitive cells ... self-renewal and the capacity to differentiate into mature cell ... as the first mouse embryonic stem cells were derived ... 1995 that the first culturing of embryonic stem cells ... not produced until 2006 As a result of these ...
(Date:2/11/2016)... 2016  Walgreens has committed to provide drug disposal ... Washington, D.C. as part of a program ... by shareholder advocacy organization As You Sow. Conrad ... people hold on to unneeded drugs because they lack easily ... --> Conrad MacKerron , Senior Vice President ...
(Date:2/11/2016)... Feb. 11, 2016  NOIT™ Research LLC, a private, ... of Change" campaign to assist needy families in obtaining ... unit sold between February 10, 2016 and March 31, ... needy family. The NOIT is an auditory stimulus that ... develop language skills. Beth Shier , ...
Breaking Medicine Technology:
(Date:2/13/2016)... Montreal, Canada (PRWEB) , ... February 13, 2016 , ... ... best foot forward. They’ll groom themselves to perfection, go out of their way to ... their date – just take a look at any online dating profile. , ...
(Date:2/12/2016)... DC (PRWEB) , ... February ... ... Siemens Foundation today announced a new initiative—the Siemens Foundation-PATH Ingenuity Fellowships—to develop ... The partnership will recruit top students from U.S. universities who will draw ...
(Date:2/12/2016)... , ... February 12, 2016 , ... As a former ... schedule, a demanding job, and no time to decompress, Rabinowitz found herself drawn to ... to meditation for its impact on her life, implementing a 20-minute-per-day meditation practice with ...
(Date:2/12/2016)... ... February 12, 2016 , ... Every winter, someone is killed, ... the West Penn Burn Center, part of the Allegheny Health Network, has ... bring you the “Space Heaters Need Space” campaign. , “Space Heaters Need ...
(Date:2/12/2016)... ... February 12, 2016 , ... Erlanger Agency has announced a new partnership in ... latest campaign focuses on the fight against breast cancer, fundraising for a local woman ... here . , Carmen is a loving single mother of two boys who also ...
Breaking Medicine News(10 mins):